Holen Sie sich die Stockscreener-App
2.33
2.93%
-0.06
Creative Medical Technology Holdings Inc Aktie (CELZ) Neueste Nachrichten
Creo Medical shares surge 27% on proposed sale of remaining European stake - Yahoo Finance
Creative Medical Technology Holdings, Inc.Common Stock (NQ: CELZ - FinancialContent
Accel Entertainment (ACEL) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance
Xtant Medical Q1 2026 Results: Revenue Guidance Raised, Balance Sheet Strengthened, Exclusive HEMOBLAST® Bellows Distribution Secured 12 - Minichart
MEDIPOST's CARTISTEM® Meets All Primary and Secondary Endpoints in Japan Phase 3 Trial and Demonstrates Statistically Significant Efficacy Gains Versus Active Control - Yahoo Finance
Incannex Healthcare Wins MedTech Breakthrough Award for Innovative Obstructive Sleep Apnea Drug IHL-42X - Minichart
Creative Global Technology Holdings And 2 Other Promising Penny Stocks - Yahoo Finance
United States shares higher at close of trade; Dow Jones Industrial Average up 0.19% - Investing.com India
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.19% - Investing.com
CELZ (CreativeMed) EPS beats estimates but shares fall nearly 3% despite narrower losses.AI Stock Signals - Newser
Creative Medical Technology Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Creative Medical Technology Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Creative Medical Technology (NASDAQ: CELZ) posts Q1 2026 loss, details cash use - Stock Titan
How CreativeMed (CELZ) prepares for market disruptions | Q3 2025: Earnings Beat EstimatesTrend Analysis - newser.com
Creative Medical Technology Holdings Inc expected to post a loss of 39 cents a shareEarnings Preview - TradingView
CVRx (CVRX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance
Theradaptive Secures FDA Approval to Advance OASIS Trial to Pivotal Study Evaluating OsteoAdapt® SP in Spinal Fusion - Yahoo Finance
Roth MKM Maintains Creative Medical Technology(CELZ.US) With Buy Rating, Maintains Target Price $20 - Moomoo
BZLEY Should I Buy - Intellectia AI
Creative Medical (CELZ) Reports Encouraging Pilot Study Results for Ultrasome Therapy - GuruFocus
Creative Medical (CELZ) Reports Promising Osteoarthritis Therapy Results - GuruFocus
BY Technical Analysis & Price Forecast - Intellectia AI
Creative Medical reports positive pilot study results for Ultrasome - Investing.com UK
Creative Medical reports positive pilot study results for Ultrasome By Investing.com - Investing.com Australia
Creative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome™ Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative Therapies - The Manila Times
Park Place Technologies Partners with Professional Athlete Genie Bouchard as 'Genie from IT” in New TV Commercial - The Manila Times
Uncertainty Around AI’s Impact on Careers Clouds Students’ College Decisions - The Manila Times
Cell-free knee arthritis therapy posts 93% response in pilot study - Stock Titan
JXHLY Forecast — Price Prediction for 2026. Should I Buy JXHLY? - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
NPSKY Technical Analysis & Stock Price Forecast - Intellectia AI
BHPCD Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Iran Hormuz Strait Crisis: Oil Market Impact & Energy Investment Strategy 2026 - Intellectia AI
NAII Technical Analysis & Price Forecast - Intellectia AI
MITT Technical Analysis & Price Forecast - Intellectia AI
RWAY Technical Analysis & Price Forecast - Intellectia AI
Creative Medical Technology Holdings, Inc. 2025 Annual Report: Executive Summary, Compensation, and Compliance Disclosures - Minichart
IBEX Technical Analysis & Price Forecast - Intellectia AI
TOVXPrice, Charts & Blockchain Insights - Intellectia AI
Creative Medical (NASDAQ: CELZ) details 2025 pay, ownership and deals - Stock Titan
VMC Technical Analysis & Price Forecast - Intellectia AI
GE Vernova Stock Analysis 2026: Q1 Earnings Beat Signals Powerhouse Momentum - Intellectia AI
HDSN Technical Analysis & Price Forecast - Intellectia AI
CreativeMed (CELZ) Volatility Analysis | Q3 2025: Profit SurprisesBest Pick - Cổng thông tin điện tử tỉnh Lào Cai
PVH Technical Analysis & Price Forecast - Intellectia AI
VIVK Technical Analysis & Price Forecast - Intellectia AI
Form 10-KAnnual report [Section 13 and 15(d), not S-K Item 405] - ADVFN
CreativeMed (CELZ) Stock Moving VWAP (Advances) 2026-04-18Rating Change - Newser
$ADA PE Ratio & Valuation, Is $ADA Overvalued - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
Trained Therapeutix Discovery’s Chief Scientific Officer, Dr. Mulder, Honored with Fellowship at the American Institute for Medical and Biological Engineering (AIMBE) - Yahoo Finance
Breakout Zone: Can Creative Medical Technology Holdings Inc continue delivering strong returns2026 Sentiment & Capital Efficient Trading Techniques - baoquankhu1.vn
Growth Review: What is the earnings history of Creative Medical Technology Holdings IncQuarterly Trade Report & Detailed Earnings Play Strategies - baoquankhu1.vn
Street Watch: Does AVPTW have a sustainable dividendPortfolio Risk Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Aug Opening: Is Sky Harbour Group Corporation being accumulated by smart money2026 Earnings Impact & Stepwise Trade Signal Guides - baoquankhu1.vn
CREATIVE MEDICAL TECHNOLOGY HOLDINGS Operating Margin %: -64 - GuruFocus
Income Plays: Is Creative Medical Technology Holdings Inc forming bullish engulfing patternsIndex Update & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Aug Weekly: Is Starwood Property Trust Inc a top pick in the sectorLayoff News & Stepwise Trade Execution Plans - baoquankhu1.vn
New Highs: What is ACCOs market positionPortfolio Update Summary & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Analysts Expect Breakeven For Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Before Long - Yahoo Finance
Leading Companies Enhancing Their Presence in the Cancer Anorexia-Cachexia Syndrome (CACS) Market - openPR.com
1.49%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):